Every single Democratic presidential candidate agrees that the federal government should take a far more aggressive approach to lowering drug prices — including letting Medicare negotiate drug prices.
But beyond that plank, there are quite a few differences between the candidates when it comes to taking on the pharmaceutical industry. To suss out exactly where they diverge, STAT questioned seven candidates during their interviews with the editorial board of the Boston Globe, STAT’s sister publication. (STAT was not involved at all with the board’s discussions about a forthcoming endorsement.)
Most of the candidates have already rolled out drug-pricing plans, and they were well-prepared to discuss an issue they said voters regularly brought up. Both Sens. Elizabeth Warren and Amy Klobuchar seemed to light up at the question, eager to engage on the topic. Former South Bend, Ind., Mayor Pete Buttigieg seemed a ready candidate, mixing politics with personal stories from the campaign trail. And Andrew Yang, who comes from the entrepreneurial world, was quick to cite a financial analyst friend in his response.